A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study to Evaluate the Efficacy of Maximally Tolerated Doses of Retigabine vs. Placebo in Reducing the Pain Associated With Post-Herpetic Neuralgia

The purpose of the study is to evaluate the efficacy of retigabine vs. placebo in reducing pain associated with post-herpetic neuralgia.

本研究旨在评估瑞替加滨（retigabine）与安慰剂（placebo）在减轻带状疱疹后遗神经痛（post-herpetic neuralgia）相关疼痛方面的疗效。